Literature DB >> 9633111

Herd immunity to filarial infection is a function of vector biting rate.

E Michael1, D A Bundy.   

Abstract

Despite the existence of an impressive body of work on human immune responses against filarial infections, the occurrence of a protective response to infection remains unclear. Here, we use a combined modelling and comparative data analysis framework to address this issue for human infections with the filarial parasite, Wuchereria bancrofti. By analogy with previous work, the analysis involves the comparison of observed field patterns of infection with epidemiological patterns predicted by a mathematical model of parasite immunity. Unlike most other human helminths, which are transmitted by ingestion or dermal penetration, exposure to infection with lymphatic filariasis can be measured explicitly in terms of vector mosquito biting rates, thereby also allowing, probably for the first time, examination of the suggested role of exposure in generating herd immunity to macroparasites. Observed field patterns in this study were derived from 19 different published studies, which gave parallel estimates of community exposure rates and the corresponding age--prevalence patterns of infection, while predictions of the epidemiological impact of herd immunity were obtained using a catalytic model framework. The results provide the first conclusive evidence to date that variations in the observed age--prevalence patterns of infection in filariasis can be effectively explained by the occurrence of an exposure-driven acquisition of herd immunity. We discuss this result in terms of implications for the new World Health Organization-led initiative for the global control of this parasitic disease.

Entities:  

Mesh:

Year:  1998        PMID: 9633111      PMCID: PMC1689054          DOI: 10.1098/rspb.1998.0370

Source DB:  PubMed          Journal:  Proc Biol Sci        ISSN: 0962-8452            Impact factor:   5.349


  36 in total

1.  Immunoepidemiology of human schistosomes: taking the theory into the field.

Authors:  M E Woolhouse
Journal:  Parasitol Today       Date:  1994-05

2.  Reinfection, exposure and immunity in human schistosomiasis.

Authors:  P Hagan
Journal:  Parasitol Today       Date:  1992-01

3.  Studies on the periodicity and intravascular distribution of Wuchereria bancrofti microfilariae in paired samples of capillary and venous blood from Recife, Brazil.

Authors:  G Dreyer; A Pimentael; Z Medeiros; F Béliz; I Moura; A Coutinho; L D de Andrade; A Rocha; L M da Silva; W F Piessens
Journal:  Trop Med Int Health       Date:  1996-04       Impact factor: 2.622

4.  Dynamics and intensity of Wuchereria bancrofti transmission in the savannah and forest regions of Liberia.

Authors:  F Kuhlow; E Zielke
Journal:  Tropenmed Parasitol       Date:  1978-09

5.  Bancroftian filariasis in Kenya II. Clinical and parasitological investigations in Mambrui, a small coastal town, and Jaribuni, a rural area more inland (Coast Province).

Authors:  D J Wijers; H Kinyanjui
Journal:  Ann Trop Med Parasitol       Date:  1977-09

6.  Standardization of criteria for assessing the effect of Simulium control in onchocerciasis control programmes.

Authors:  J F Walsh; J B Davies; R Le Berre; R Grams
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

Review 7.  Immunoepidemiology of lymphatic filariasis: the relationship between infection and disease.

Authors:  D A Bundy; B T Grenfell; P K Rajagopalan
Journal:  Immunol Today       Date:  1991-03

8.  A multidisciplinary study on bancroftian filariasis in Jakarta.

Authors:  L S Self; S Usman; H Sajioiman; F Partono; M J Nelson; C P Pant; T Suzuki; H Mechfudin
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

9.  On the inefficiency of transmission of Wuchereria bancrofti from mosquito to human host.

Authors:  N G Hairston; B de Meillon
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

10.  Analysis of the Wuchereria bancrofti population in the people of American Samoa.

Authors:  N G Hariston; L A Jachowski
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

View more
  11 in total

1.  Multivalent vaccine formulation with BmVAL-1 and BmALT-2 confer significant protection against challenge infections with Brugia malayi in mice and jirds.

Authors:  Ramaswamy Kalyanasundaram; Padmavathi Balumuri
Journal:  Res Rep Trop Med       Date:  2011-03

2.  Population biology of human onchocerciasis.

Authors:  M G Basáñez; M Boussinesq
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

3.  Transmission intensity affects both antigen-specific and nonspecific T-cell proliferative responses in Loa loa infection.

Authors:  Jean Paul Akue; Eileen Devaney
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

4.  Symptomatic human neurocysticercosis--age, sex and exposure factors relating with disease heterogeneity.

Authors:  Agnès Fleury; Alain Dessein; Pierre Marie Preux; Michel Dumas; Graciela Tapia; Carlos Larralde; Edda Sciutto
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

5.  Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis.

Authors:  Manoj Gambhir; Moses Bockarie; Daniel Tisch; James Kazura; Justin Remais; Robert Spear; Edwin Michael
Journal:  BMC Biol       Date:  2010-03-17       Impact factor: 7.431

6.  Immunoepidemiology of Wuchereria bancrofti infection: parasite transmission intensity, filaria-specific antibodies, and host immunity in two East African communities.

Authors:  Walter G Jaoko; Edwin Michael; Dan W Meyrowitsch; Benson B A Estambale; Mwele N Malecela; Paul E Simonsen
Journal:  Infect Immun       Date:  2007-10-01       Impact factor: 3.441

7.  Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling.

Authors:  Wilma A Stolk; Sake J de Vlas; J Dik F Habbema
Journal:  Filaria J       Date:  2006-03-28

8.  Assessing endgame strategies for the elimination of lymphatic filariasis: A model-based evaluation of the impact of DEC-medicated salt.

Authors:  Morgan E Smith; Brajendra K Singh; Edwin Michael
Journal:  Sci Rep       Date:  2017-08-07       Impact factor: 4.379

9.  Heterogeneous dynamics, robustness/fragility trade-offs, and the eradication of the macroparasitic disease, lymphatic filariasis.

Authors:  Edwin Michael; Brajendra K Singh
Journal:  BMC Med       Date:  2016-01-28       Impact factor: 8.775

10.  Understanding heterogeneities in mosquito-bite exposure and infection distributions for the elimination of lymphatic filariasis.

Authors:  Michael A Irvine; James W Kazura; T Deirdre Hollingsworth; Lisa J Reimer
Journal:  Proc Biol Sci       Date:  2018-01-31       Impact factor: 5.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.